World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
33103
World Ranking
10475
National Ranking
5389

Brian M. Wolpin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Brian M. Wolpin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 360 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Brian M. Wolpin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Brian M. Wolpin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Brian M. Wolpin is affiliated with Harvard University in the United States. Their research spans multiple fields, primarily focusing on medicine and biochemistry, genetics, and molecular biology. Within these broad areas, their work concentrates on several subfields including oncology, molecular biology, cancer research, pulmonary and respiratory medicine, and surgery.

The scientist's research topics display a strong emphasis on oncology-related studies, particularly pancreatic and hepatic oncology research. Other main areas of interest include cancer genomics and diagnostics, cancer immunotherapy and biomarkers, cancer cells and metastasis, epigenetics and DNA methylation, renal cell carcinoma treatment, and colorectal cancer treatments and studies.

Brian M. Wolpin has authored numerous papers published in various respected scientific journals. Notable recent publications include:

  • Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology (2021) in the Journal of the National Comprehensive Cancer Network
  • Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer (2021) in Cell
  • BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial (2020) in Nature Medicine
  • The Mediterranean diet, plasma metabolome, and cardiovascular disease risk (2020) in European Heart Journal
  • Low glycaemic diets alter lipid metabolism to influence tumour growth (2021) in Nature

The scientist frequently collaborates with fellow researchers with whom they have multiple joint publications. Prominent co-authors include Andrew J. Aguirre, James M. Cleary, Lauren K. Brais, Kimmie Ng, and Jonathan A. Nowak.

Brian M. Wolpin's work has been distributed widely across several notable publication venues, reflecting the scope of their research output. These journals are:

  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Cancer Epidemiology Biomarkers & Prevention
  • Nature Communications

Best Publications

  • Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

    Vasanthi S. Viswanathan;Matthew J. Ryan;Harshil D. Dhruv;Shubhroz Gill

  • Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Horacio Asbun

  • Pancreatic adenocarcinoma, Version 2.2021

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Stephen W. Behrman

  • Organoid profiling identifies common responders to chemotherapy in pancreatic cancer

    Hervé Tiriac;Pascal Belleau;Dannielle D Engle;Dennis Plenker

  • Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer

    Laufey Amundadottir;Peter Kraft;Rachael Z. Stolzenberg-Solomon;Charles S. Fuchs

  • A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33

    Gloria M. Petersen;Laufey Amundadottir;Charles S. Fuchs;Peter Kraft

  • Systemic Treatment of Colorectal Cancer

    Brian M. Wolpin;Robert J. Mayer

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder

  • Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

    Jared R Mayers;Chen Wu;Chen Wu;Clary B Clish;Peter Kraft

  • Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases A Mendelian Randomization Study

    Philip C Haycock;Stephen Burgess;Aayah Nounu

  • Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers

    Jared R. Mayers;Margaret E. Torrence;Laura V. Danai;Thales Papagiannakopoulos

  • ABO Blood Group and the Risk of Pancreatic Cancer

    Brian M. Wolpin;Andrew T. Chan;Patricia Hartge;Stephen J. Chanock

  • Pancreatic Adenocarcinoma, Version 2.2014

    Margaret A. Tempero;Mokenge P. Malafa;Stephen W. Behrman;Al B. Benson

  • Acquired Resistance to KRASG12C Inhibition in Cancer

    Mark M Awad;Shengwu Liu;Igor I Rybkin;Kathryn C Arbour

  • Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

    Alan A. Arslan;Kathy J. Helzlsouer;Charles Kooperberg;Xiao Ou Shu

  • Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma

    Brian M. Wolpin;Douglas A. Rubinson;Xiaoxu Wang;Jennifer A. Chan

  • BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Bruno Bockorny;Bruno Bockorny;Valerya Semenisty;Teresa Macarulla;Erkut Borazanci

  • Adjuvant treatment of colorectal cancer.

    Brian M. Wolpin;Jeffrey A. Meyerhardt;Harvey J. Mamon;Robert J. Mayer

  • Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers

    J. R. Mayers;M. E. Torrence;L. V. Danai;T. Papagiannakopoulos

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Meredith Yeager;Weiyin Zhou;Sholom Wacholder

Frequent Co-Authors

Peter Kraft
Peter Kraft Harvard University
Laufey T. Amundadottir
Laufey T. Amundadottir National Institutes of Health
J. Michael Gaziano
J. Michael Gaziano Brigham and Women's Hospital
Julie E. Buring
Julie E. Buring Brigham and Women's Hospital
Alison P. Klein
Alison P. Klein Johns Hopkins University
Howard D. Sesso
Howard D. Sesso Harvard Medical School
Harvey A. Risch
Harvey A. Risch Yale University
Dimitrios Trichopoulos
Dimitrios Trichopoulos Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career isn’t limited to traditional MD routes. Today, a variety of online direct entry msn programs for non-nursing majors offer a fast-track into advanced nursing for students with a bachelor’s degree in another field. These accelerated options provide a flexible path to entering healthcare without starting from scratch.

For those interested in patient care but not ready for a master’s, online bsn programs for non nurses open doors to becoming a Registered Nurse. These programs are designed for career changers and often feature streamlined admission requirements.

The medical field also needs skilled professionals behind the scenes. online medical billing and coding with financial aid programs train students for vital administrative roles, often in under two years, and can be completed entirely online.

If you’re looking for quicker entry into healthcare, lpn school without teas test options allow you to skip lengthy entrance exams and start your training sooner.

These alternative pathways make it easier than ever to launch a rewarding healthcare career without a traditional medical degree.

Best Scientists Citing Brian M. Wolpin

Trending Scientists

Recently Published Articles